ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: decent who wrote (146)	12/9/1998 11:27:00 PM
From: Panita	Read Replies (1) of 1084

We are sitting below the IPO price. ASTM has reached the third base and is just a few steps away from home plate and the fruits of their work. We can consider ourselves lucky to have this gift. We can buy this stock now when the fruit is ripe for the eating. We should be glad that we can buy now below or around the IPO price. One big different between ASTM and the likes of GERN is that ASTM products are around corner; GERN products are year away. ENMD went from low single digits to high of 80's within hours. ASTM with viable products now is a better story. Furthermore it is great to own a company that is saving lives.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next